Viking Therapeutics, Inc (VKTX) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "VKTX"
      ],
      "issuer_cik": "0001607678",
      "owner_cik": "0001614578",
      "accession_number": "0001193125-26-324448",
      "form_type": "4",
      "filing_date": "2026-07-29",
      "period_of_report": "2026-07-28",
      "issuer_name": "Viking Therapeutics, Inc.",
      "issuer_trading_symbol": "VKTX",
      "owner_name": "Lian Brian",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "President & CEO",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock, par value $0.00001 per share",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-07-29",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 148517,
      "transaction_price_per_share": 33.3153,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 2572441,
      "transaction_value": 4947888.4101,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F2",
          "description": "These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."
        },
        {
          "id": "F3",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.82 to $33.77, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."
        }
      ]
    },
    {
      "tickers": [
        "VKTX"
      ],
      "issuer_cik": "0001607678",
      "owner_cik": "0001838112",
      "accession_number": "0001193125-26-324446",
      "form_type": "4",
      "filing_date": "2026-07-29",
      "period_of_report": "2026-07-28",
      "issuer_name": "Viking Therapeutics, Inc.",
      "issuer_trading_symbol": "VKTX",
      "owner_name": "Mancini Marianna",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "Chief Operating Officer",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock, par value $0.00001 per share",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-07-29",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 18217,
      "transaction_price_per_share": 33.4652,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 422760,
      "transaction_value": 609635.5484000001,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F3",
          "description": "These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1."
        },
        {
          "id": "F4",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.28 to $33.805, inclusive. The Reporting Person  undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.